title: Exceptional responses or TRIPS over red tape?
authors.forename: Steve
authors.initials: S
authors.lastname: Cockburn
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000191:economics* / Q000493:pharmacokinetics; D006801:Humans; D018973:Intellectual Property; D007880:Legislation, Drug; D013810:Therapeutic Equivalency
chemical_list: D019380:Anti-HIV Agents